Ysios news
16.09.14
AM-Pharma closes €12.2m financing round
23.04.14
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
portfolio news
20.01.15
AM-Pharma starts Adaptive Phase II trial of recAP in Acute Kidney Injury
22.12.14
TiGenix submits its pivotal US trial design for Cx601 to the FDA for Special Protocol Assessment
